30th Anniversary of NL Ride for Sight
The 30th anniversary Ride for Sight Newfoundland and Labrador raised over $150,000 for the Foundation Fighting Blindness and sight saving research.
Some of those funds are returning to the province with Dr. Robert Gendron of Memorial University recently awarded a research grant to help his team study the underlying causes of age-related macular degeneration (AMD) – a disease affecting over one million Canadians.
Dr. Gendron is one of seven researchers across the country who obtained funding from the Foundation Fighting Blindness in 2012 through grants made possible in part by Ride for Sight.
Sept. 29, Dr. Gendron will be joined by more of the country’s top retinal scientists in St. John’s for ‘ Vision Quest’ – the Foundation Fighting Blindness’ annual patient conference. At Vision Quest people and families affected by vision loss will learn directly from the experts about the latest in sight- saving research and the future of treatments and cures.
Ride for Sight Director Debbie Dixon said “For 30 years, Newfoundland motorcyclists have been dedicated to the fight against blindness. The Ride for Sight 2012 event marked an incredible milestone for our riders and for individuals and families living with vision loss.
“We couldn’t have done it without the generous support of our sponsors, riders, donors, volunteers, our tireless planning committee, and the Town of Gander and we’re thrilled that those dollars are coming back to the island.”
Special celebrity guest for this year’s ride June 24 weekend, Jim Caruk of HGTV’s Builder Boss, said “This was my first time at Ride for Sight in Newfoundland and it was unforgettable. The weekend was jam-packed, and I enjoyed sharing road stories with folks who have made Ride for Sight a yearly tradition for three decades.”
Ride for Sight will return to Gander in 2013. To get involved visit ‘www.rideforsight.com’, and email ‘firstname.lastname@example.org’ for more details.
The Foundation Fighting Blindness is Canada’s largest charity for sight saving research. It has contributed over $20 million to cutting edge research into the causes, treatments and cures for retinitis pigmentosa, macular degeneration and related retinal eye diseases.